Health Care: Drugs

Trinity Biotech PLC (TRIB: NASDAQ)

$7.06 n/a | n/a%
10/21/16 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 7.06
52 Week High 13.68
52 Week Low 5.76
Avg. Daily Vol. (Mil) 0.25
Beta (3 year) 0.97
Share Related Items
Mkt Cap (Mil) 169.16
Shares Out (Mil) 23.96
Float (Mil) 0.00
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 96.00
Financial Strength
Quick Ratio 6.10
Current Ratio 7.90
LT Debt/ Equity 0.47
Total Debt / Equity 0.47
Valuation Ratios
Price Earnings 30.20
Price/Sales 1.72
Price/Book 0.80
Price/Cash Flow 7.70
Per Share Data
Earnings 0.23
Sales 4.11
Book Value 8.87
Cash Flow 0.92
Business Summary
Trinity Biotech PLC develops, acquires, manufactures & markets medical diagnostic products for clinical laboratory & point-of-care of diagnostic market. Its products are used to detect autoimmune, infectious, diabetes and disorders of liver & intestine.
General Information
IDA Business Park
Industry : Drugs
Sector: Health Care
Employees: 568
CEO: Ronan O'Caoimh
Short Interest
Current Month (Mil) 1.64
Previous Month (Mil) 1.64
Short Interest Ratio (Days) 31.00
Management Effectiveness
Return on Equity 7.70
Return on Assets 4.60
Return on Investments 5.30
Gross Margin 48.00
EBIT Margin 23.00
Profit Margin 16.70

Portfolios with TRIB

Latest TRIB Headlines from TheStreet

More Financial News for TRIB

Press Releases for TRIB

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter